A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease

Journal of Vascular Surgery

Volumn 57, Issue 1, 2013, Pages 242-253

  Antoniou, George A ^a   Chalmers, Nicholas ^a   Georgiadis, George S ^b   Lazarides, Miltos K ^b   Antoniou, Stavros A ^c   Serracino Inglott, Ferdinand ^a   Smyth, J Vincent ^a   Murray, David ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPUTATION; ARTERY DISEASE; ARTERY RECONSTRUCTION; BYPASS SURGERY; ENDOVASCULAR SURGERY; FEMOROPOPLITEAL ARTERIAL DISEASE; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMPUTATION; COMORBIDITY; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84871607280     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.07.038     Document Type: Review

References (46)

1. J.D. Santilli, S.M. Santilli Chronic critical limb ischemia: diagnosis, treatment and prognosis Am Fam Physician 59 1999 1899 1908
2. S. Gandhi, I. Weinberg, R. Margey, M.R. Jaff Comprehensive medical management of peripheral arterial disease Prog Cardiovasc Dis 54 2011 2 13
3. C. Kasapis, H.S. Gurm Current approach to the diagnosis and treatment of femoral-popliteal arterial disease A systematic review Curr Cardiol Rev 5 2009 296 311
4. P. Burns, S. Gough, A.W. Bradbury Management of peripheral arterial disease in primary care BMJ 326 2003 584 588
5. K.D. Wölfle, H. Bruijnen, H. Loeprecht, G. Rümenapf, H. Schweiger, K. Grabitz Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis Eur J Vasc Endovasc Surg 25 2003 229 234
6. S. Gandhi, R. Sakhuja, D.P. Slovut Recent advances in percutaneous management of iliofemoral and superficial femoral artery disease Cardiol Clin 29 2011 381 394
7. F. Fowkes, G.C. Leng Bypass surgery for chronic lower limb ischaemia Cochrane Database Syst Rev 2 2008 CD002000
8. S. Sultan, N. Hynes Five-year Irish trial of CLI patients with TASC II type C/D lesions undergoing subintimal angioplasty or bypass surgery based on plaque echolucency J Endovasc Ther 16 2009 270 283
9. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
10. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17 1996 1 12
11. H.D. Clark, G.A. Wells, C. Huët, F.A. McAlister, L.R. Salmi, D. Fergusson Assessing the quality of randomized trials: Reliability of the Jadad scale Control Clin Trials 20 1999 448 452
12. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical- epidemiology/oxford.asp Accessed November 15, 2011
13. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
14. J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
15. M. Egger, G. Davey Smith, M. Schneider, C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
16. N. Hynes, Y. Akhtar, B. Manning, M. Aremu, K. Oiakhinan, D. Courtney Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease J Endovasc Ther 11 2004 460 471
17. G.L. Wolf, S.E. Wilson, A.P. Cross, R.H. Deupree, W.B. Stason Surgery or balloon angioplasty for peripheral vascular disease: A randomized clinical trial Principal Investigators and their Associates of Veterans Administration Cooperative Study Number 199 J Vasc Interv Radiol 4 1993 639 648
18. J. Holm, B. Arfvidsson, L. Jivegård, F. Lundgren, K. Lundholm, T. Scherstén Chronic lower limb ischaemia A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA) Eur J Vasc Surg 5 1991 517 522
19. S.E. Wilson, G.L. Wolf, A.P. Cross Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis Report of a prospective randomized trial in a selected group of patients J Vasc Surg 9 1989 1 9
20. M.V. Cvetanovski, S. Jovev, M. Cvetanovska, B. Blazevski, R. Colanceski, T. Andreevska Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results Prilozi 30 2009 105 118
21. P.N. Suding, W. McMaster, E. Hansen, A.W. Hatfield, I.L. Gordon, S.E. Wilson Increased endovascular interventions decrease the rate of lower limb artery bypass operations without an increase in major amputation rate Ann Vasc Surg 22 2008 195 199
22. N.D. Karanjia, T.M. Loosemore, S.A. Ray, T.M. Buckenham, R.S. Taylor, J.A. Dormandy The differences in early haemodynamic response between surgery and angioplasty after successful re-opening of the superficial femoral artery Eur J Vasc Surg 7 1993 717 719
23. K. McQuade, D. Gable, S. Hohman, G. Pearl, B. Theune Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 49 2009 109 115
24. K. McQuade, D. Gable, G. Pearl, B. Theune, S. Black Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 52 2010 584 590
25. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification J Vasc Surg 51 5 Suppl 2010 32S 42S
26. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie BASIL trial participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making J Vasc Surg 51 5 Suppl 2010 52S 68S
27. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie BASIL trial participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy J Vasc Surg 51 5 Suppl 2010 5S 17S
28. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie BASIL trial participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received J Vasc Surg 51 5 Suppl 2010 18S 31S
29. J.F. Forbes, D.J. Adam, J. Bell, F.G. Fowkes, I. Gillespie, G.M. Raab BASIL trial participants Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis J Vasc Surg 51 5 Suppl 2010 43S 51S
30. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease The bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial Health Technol Assess 14 2010 1 210 iii-iv
31. M. Lepäntalo, K. Laurila, W.D. Roth, P. Rossi, J. Lavonen, K. Mäkinen Scandinavian Thrupass Study Group PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial Eur J Vasc Endovasc Surg 37 2009 578 584
32. J. Kedora, S. Hohmann, W. Garrett, C. Munschaur, B. Theune, D. Gable Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease J Vasc Surg 45 2007 10 16
33. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, J.F. Forbes BASIL trial participants Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
34. E.S. van der Zaag, D.A. Legemate, M.H. Prins, J.A. Reekers, M.J. Jacobs Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial Eur J Vasc Endovasc Surg 28 2004 132 137
35. S.T. Scali, E.M. Rzucidlo, A.A. Bjerke, D.H. Stone, D.B. Walsh, P.P. Goodney Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease J Vasc Surg 54 2011 714 721
36. M. Korhonen, F. Biancari, M. Söderström, E. Arvela, K. Halmesmäki, A. Albäck Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: A propensity score analysis Eur J Vasc Endovasc Surg 41 2011 378 384
37. A.K. Ah Chong, C.B. Tan, M.W. Wong, F.S. Cheng Bypass surgery or percutaneous transluminal angioplasty to treat critical lower limb ischaemia due to infrainguinal arterial occlusive disease? HK Med J 15 2009 249 254
38. H.H. Dosluoglu, G.S. Cherr, P. Lall, L.M. Harris, M.L. Dryjski Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-society Consensus-II C and D superficial femoral artery disease J Vasc Surg 48 2008 1166 1174
39. J.M. Blair, B.L. Gewertz, H. Moosa, C.T. Lu, C.K. Zarins Percutaneous transluminal angioplasty versus surgery for limb-threatening ischemia J Vasc Surg 9 1989 698 703
40. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration BMJ 339 2009 b2700
41. G.M. Ansel, A.B. Lumsden Evolving modalities for femoropopliteal interventions J Endovasc Ther 16 Suppl 2 2009 II82 II97
42. J.H. Rogers, J.R. Laird Overview of new technologies for lower extremity revascularization Circulation 116 2007 2072 2085
43. A.R. Geronemus, C.S. Peña Endovascular treatment of femoral-popliteal disease Semin Intervent Radiol 26 2009 303 314
44. P.H. Lin, S.M. Weakley, P. Kougias How to interpret data from the superficial femoral artery stenting trials and registries Semin Vasc Surg 23 2010 138 147
45. G.A. Antoniou, G.S. Sfyroeras, C. Karathanos, H. Achouhan, S. Koutsias, G. Vretzakis Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease Eur J Vasc Endovasc Surg 38 2009 616 622
46. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, M. Buchbinder RESILIENT Investigators Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276